{"DataElement":{"publicId":"2006961","version":"4","preferredName":"Prior Systemic Therapy Administered Ind-2","preferredDefinition":"the yes/no indicator to determine if a patient has been given systemic therapy prior to a study.","longName":"PRIO_SYSTX_ADM_IND-2","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195087","version":"1","preferredName":"Prior Systemic Therapy Administered","preferredDefinition":"information related to the prior systemic therapy administered.","longName":"PRIOR_SYSTX_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206845","version":"1","preferredName":"Prior Systemic Therapy","preferredDefinition":"Earlier in time or order.:(sis-TEM-ik THER-a-pee) Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.","longName":"C25629:C15698","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Systemic Therapy","conceptCode":"C15698","definition":"Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0AE3-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177665","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"Administered","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-516D-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ECF2382B-D848-4E2D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008586","version":"2","longName":"Type of Category","context":"CIP","ClassificationSchemeItems":[{"publicId":"2811779","version":"1","longName":"TREATMENT","context":"CIP"}]},{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811912","version":"1","longName":"Head and Neck","context":"CTEP"},{"publicId":"2811910","version":"1","longName":"Prostate","context":"CTEP"},{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"},{"publicId":"2812017","version":"1","longName":"Phase II Lung Cancer","context":"CTEP"},{"publicId":"2811832","version":"1","longName":"Lung","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000614","version":"1","longName":"Palliative Head/Neck","context":"CTEP"},{"publicId":"2811821","version":"1","longName":"SCLC 2nd Line","context":"CTEP"},{"publicId":"2811822","version":"1","longName":"SCLC Extensive","context":"CTEP"},{"publicId":"2811823","version":"1","longName":"SCLC Limited","context":"CTEP"},{"publicId":"2811810","version":"1","longName":"NSCLC 2nd Line","context":"CTEP"},{"publicId":"10000001","version":"1","longName":"NSCLC Advanced","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]},{"publicId":"4631580","version":"1","longName":"Exceptional Responder CDEs","context":"CTEP","ClassificationSchemeItems":[{"publicId":"4631582","version":"1","longName":"Exceptional Responder CDEs","context":"CTEP"}]},{"publicId":"6147165","version":"1","longName":"Wake Forest Baptist Medical Center","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6147167","version":"1","longName":"WFB","context":"NCIP"}]}],"AlternateNames":[{"name":"PRIO_SYSTX_ADM_IND-2","type":"USED_BY","context":"CCR"},{"name":"0001159","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0002532","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"DCI","type":"USED_BY","context":"DCI"},{"name":"PRIO_SYSTX_ADM_IND-2","type":"USED_BY","context":"Alliance"},{"name":"PRIO_SYSTX_ADM_IND-2","type":"USED_BY","context":"CTEP"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"PRIO_SYSTX_ADM_IND-2","type":"USED_BY","context":"CITN"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"}],"ReferenceDocuments":[{"name":"Prior systemic therapy","type":"Preferred Question Text","description":"Prior systemic therapy","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Any prior systemic therapy for NHL other than involved field radiation therapy","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Did the patient receive any prior systemic therapy","url":null,"context":"CTEP"},{"name":"Did patient receive prior systemic therapy?","type":"Alternate Question Text","description":"Did patient receive prior systemic therapy?","url":null,"context":"NCIP"},{"name":"AECC Text","type":"Alternate Question Text","description":"Prior systemic therapy for metastatic disease","url":null,"context":"AECC"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Prior systemic (cancer) therapy for this tumor","url":null,"context":"CTEP"},{"name":"Did the patient have systemic treatment for non-Melanoma cancer?","type":"Alternate Question Text","description":"Did the patient have systemic treatment for non-Melanoma cancer?","url":null,"context":"DCI"},{"name":"Did the patient have systemic treatment for Non-Melanoma cancer?","type":"Alternate Question Text","description":"Did the patient have systemic treatment for Non-Melanoma cancer?","url":null,"context":"DCI"},{"name":"NRG_Text1","type":"Alternate Question Text","description":"First-line standard systemic therapy (chemotherapy,anti-endocrine therapy,anti-HER2 or other standard targeted therapy) for metastatic breast cancer that has exceeded a duration of 6 months at the time of registration?","url":null,"context":"NRG"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Prior systemic therapy administered","url":null,"context":"CTEP"},{"name":"ECOG CRF Text 1","type":"Alternate Question Text","description":"Prior systemic therapy for unresectable stage III or IV melanoma","url":null,"context":"ECOG-ACRIN"},{"name":"CITN","type":"Alternate Question Text","description":"Systemic Therapy","url":null,"context":"CITN"},{"name":"NRG_TEXT3","type":"Alternate Question Text","description":"If required first line standard systemic therapy (chemotherapy, anti-endocrine therapy, anti-HER2 or other standard targeted therapy) for metastatic breast cancer was given prior to study entry did it exceed a duration of 12 months at the time of registration?","url":null,"context":"NRG"},{"name":"NRG Text2","type":"Alternate Question Text","description":"First line standard systemic chemotherapy?","url":null,"context":"NRG"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Has the patient received adjuvant systemic therapy?","url":null,"context":"Alliance"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Prior adjuvant systemic therapy for this tumor","url":null,"context":"Alliance"},{"name":"CRF Text6","type":"Alternate Question Text","description":"did the patient receive adjuvant systemic therapy for this tumor after surgery","url":null,"context":"Alliance"},{"name":"Prior Therapy","type":"Alternate Question Text","description":"Did the patient receive prior systemic treatment regimens (including cytotoxic chemotherapy, targeted therapy, immunotherapy)?","url":null,"context":"ECOG-ACRIN"},{"name":"PBTC_Text1","type":"Alternate Question Text","description":"Has the patient received and failed standard frontline therapy for medulloblastoma?","url":null,"context":"PBTC"},{"name":"PBTC_Text2","type":"Alternate Question Text","description":"Has the patient received and failed standard therapy for medulloblastoma that included radiation therapy?","url":null,"context":"PBTC"},{"name":"CRF Text8","type":"Alternate Question Text","description":"One prior line of systemic therapy for multiple myeloma?","url":null,"context":"Alliance"},{"name":"CRF Text7","type":"Alternate Question Text","description":"<1 year from diagnosis to systemic treatment","url":null,"context":"Alliance"},{"name":"WF-1806","type":"Alternate Question Text","description":"Prior systemic chemotherapy for metastatic colorectal cancer (ok if adjuvant chemotherapy completed >= 12 months prior to disease recurrence).","url":null,"context":"NCIP"},{"name":"WF-1806v2","type":"Alternate Question Text","description":"Prior systemic chemotherapy for metastatic colorectal cancer (acceptable if adjuvant chemotherapy completed >= 12 months prior to disease recurrence).","url":null,"context":"NCIP"},{"name":"CRF Text10","type":"Alternate Question Text","description":"Has the patient had prior adjuvant systemic therapy for this tumor?","url":null,"context":"Alliance"},{"name":"CRF Text9","type":"Alternate Question Text","description":"Prior lines of systemic therapy?","url":null,"context":"Alliance"},{"name":"PBTC_Text3","type":"Alternate Question Text","description":"Has the patient received and failed standard therapy for primary brain or spinal tumor that included radiation therapy?","url":null,"context":"PBTC"},{"name":"PBTC_Text4","type":"Alternate Question Text","description":"Has patient not had any prior antitumor therapy except surgery and or steroids?","url":null,"context":"PBTC"},{"name":"CRF Text11","type":"Alternate Question Text","description":"Prior Treatment with Systemic Anticancer Therapy","url":null,"context":"Alliance"},{"name":"PBTC_Text5","type":"Alternate Question Text","description":"Has the patient received and failed at least 1 standard, tumor-directed therapy for primary brain or spinal tumor besides surgery?","url":null,"context":"PBTC"},{"name":"PBTC_Text6","type":"Alternate Question Text","description":"Has the patient received and failed standard therapy for medulloblastoma?","url":null,"context":"PBTC"},{"name":"CRF Text12","type":"Alternate Question Text","description":"History of prior systemic anti-cancer therapy including investigational agents within 4 weeks prior to treatment?","url":null,"context":"Alliance"},{"name":"PBTC_Text7","type":"Alternate Question Text","description":"Has the patient received at least one antitumor therapy other than surgery?","url":null,"context":"PBTC"},{"name":"PBTC_Text8","type":"Alternate Question Text","description":"Has the patient received standard of care therapy including maximal safe surgical resection followed by local adjuvant radiation therapy prior to enrollment?","url":null,"context":"PBTC"},{"name":"NRG_Text_4","type":"Alternate Question Text","description":"Did the patient receive more than 2 prior lines of systemic therapy?","url":null,"context":"NRG"},{"name":"WF-1806 Text 1","type":"Alternate Question Text","description":"Prior systemic chemotherapy for metastatic colorectal cancer (acceptable if adjuvant chemotherapy completed >= 3 months (12 weeks) prior to this recurrence and treatment.","url":null,"context":"NCIP"},{"name":"WF-1806 V3","type":"Alternate Question Text","description":"Prior systemic chemotherapy for metastatic colorectal cancer (acceptable if adjuvant chemotherapy completed >= 3 months (12 weeks) prior to this disease recurrence and treatment).","url":null,"context":"NCIP"},{"name":"CRF text13","type":"Alternate Question Text","description":"Prior systemic treatment with either corticosteroids or other immunosuppressive medications?","url":null,"context":"Alliance"},{"name":"Alliance - 1","type":"Alternate Question Text","description":"Prior systemic treatment for active autoimmune disease?","url":null,"context":"Alliance"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Did patient receive new immunosuppressive medication or extra-corporeal photopheresis initiated in the 4 weeks prior to enrollment?","url":null,"context":"COG"},{"name":"Alliance - 2","type":"Alternate Question Text","description":"Prior systemic therapy?","url":null,"context":"Alliance"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Does the patient require systemic treatment with either corticosteroids or other immunosuppressive medications within 14 days prior to enrollment?","url":null,"context":"COG"},{"name":"Alliance A092105","type":"Alternate Question Text","description":"Prior systemic therapy for recurrent, metastatic NPC?","url":null,"context":"Alliance"},{"name":"NRG_Text_5","type":"Alternate Question Text","description":"Did the patient have 5 or less prior lines of systemic therapy?","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D0F6CEC0-8293-50B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-15","endDate":null,"createdBy":"PWEST","dateCreated":"2004-01-15","modifiedBy":"TYRRELLM","dateModified":"2023-10-22","changeDescription":"12/11/14 jc added Exceptional Responder CSI.  Replaced VD Therapy Ind-2 2018279v1 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"2023.10.22_Added AQT per request ticket CADSR0002989_mmt\r\n2023/4/4: Added AQT for Alliance.wz","unresolvedIssues":null,"deletedIndicator":"No"}}